Vitamin K2 MK-7: The Nutrient That Directs Calcium to Your Bones Not Arteries

Vitamin K2 MK-7: The Nutrient That Directs Calcium to Your Bones Not Arteries

Most people have heard that calcium builds strong bones and that vitamin D helps absorb it. That’s where the public health messaging usually stops. But there’s a critical third player in this system that almost nobody talks about, and without it, the calcium you’re carefully supplementing or consuming through dairy could end up in exactly the wrong places — your arterial walls, your kidneys, your soft tissues — instead of your skeleton.

Here’s the thing most people miss about this topic.

Here’s the thing most people miss about this topic.

Related: evidence-based supplement guide

After looking at the evidence, a few things stood out to me.

That player is vitamin K2, specifically the form known as MK-7 (menaquinone-7). If you’re a knowledge worker spending long hours at a desk, probably not getting much sun, possibly supplementing with vitamin D and calcium, and not thinking much about K2 — this matters more than you might expect.

What Vitamin K2 Actually Is (And Why It’s Not K1)

Vitamin K is typically lumped into a single category in nutrition discussions, but K1 and K2 are functionally quite different. Vitamin K1 (phylloquinone) is found in green leafy vegetables and is primarily involved in blood clotting. Your liver uses it efficiently, and you’re probably getting enough of it if you eat any vegetables at all.

Vitamin K2 is a family of compounds called menaquinones, numbered MK-4 through MK-13 based on the length of their side chains. MK-4 is found in small amounts in animal products, but MK-7 — the form most relevant to bone and cardiovascular health — is produced primarily by bacteria during fermentation. The richest dietary source is natto, a fermented soybean dish common in Japan. Most Westerners don’t eat natto regularly (or at all), which is part of why K2 deficiency is widespread in Western populations.

MK-7 has a significantly longer half-life in the body than MK-4. While MK-4 clears the bloodstream within hours, MK-7 remains active for several days, allowing for more consistent activation of K2-dependent proteins throughout the body (Schurgers et al., 2007). This is why MK-7 is considered the superior supplemental form for long-term benefits.

The Calcium Paradox: How a Healthy Mineral Becomes a Problem

Here’s the situation that makes K2 so important: calcium is essential, but calcium in the wrong location is dangerous. Arterial calcification — the hardening of blood vessels due to calcium deposits — is one of the primary mechanisms behind cardiovascular disease. Meanwhile, many adults in developed countries are simultaneously experiencing osteoporosis and arterial calcification. They’re losing calcium from their bones while their arteries are calcifying.

This isn’t a coincidence. It’s sometimes called the calcium paradox, and vitamin K2 deficiency is one of the central explanations for it. The body needs specific proteins to direct calcium to bones and keep it out of soft tissues. Those proteins are K2-dependent — they require K2 to become activated. Without adequate K2, these proteins stay in an inactive (carboxylated) state and simply can’t do their job.

Think of K2 as the traffic controller at a busy intersection. Calcium is the traffic. Without the controller, cars end up where they don’t belong.

The Two Key Proteins K2 Activates

Osteocalcin: The Bone Builder

Osteocalcin is produced by osteoblasts, the cells responsible for bone formation. It’s one of the most abundant proteins in bone tissue, and its job is to bind calcium and anchor it into the bone matrix. The catch: osteocalcin only functions properly when it’s carboxylated, a process that requires vitamin K2.

When K2 is insufficient, osteocalcin is secreted in an undercarboxylated form. It circulates in the blood without being able to bind calcium effectively. Undercarboxylated osteocalcin (ucOC) is actually used clinically as a marker of vitamin K2 status — higher levels of ucOC indicate K2 deficiency and are associated with lower bone mineral density and increased fracture risk.

Research has demonstrated that MK-7 supplementation significantly reduces ucOC levels and improves osteocalcin carboxylation, with downstream effects on bone strength and density (Knapen et al., 2013). In a three-year randomized controlled trial involving postmenopausal women, daily MK-7 supplementation improved bone mineral density and reduced bone loss at the lumbar spine and femoral neck compared to placebo.

Matrix Gla Protein: The Arterial Guardian

Matrix Gla Protein (MGP) is arguably even more important for understanding the cardiovascular side of the K2 story. MGP is one of the most potent inhibitors of vascular calcification known to science. It’s produced by vascular smooth muscle cells and chondrocytes, and its entire purpose is to prevent calcium from depositing in arterial walls and cartilage.

Like osteocalcin, MGP requires K2 for activation. Inactive (undercarboxylated) MGP cannot inhibit calcification. In animal studies, MGP knockout mice develop severe arterial calcification and die within weeks from cardiovascular complications — which powerfully demonstrates just how critical this protein is.

In human research, higher levels of inactive MGP are associated with increased arterial stiffness, increased cardiovascular risk, and higher all-cause mortality. Conversely, adequate K2 intake — particularly from MK-7 — is associated with lower arterial stiffness and reduced calcification. A landmark study from the Rotterdam cohort found that high dietary intake of menaquinones (K2) was associated with a 57% reduction in risk of dying from cardiovascular disease (Geleijnse et al., 2004). Notably, K1 intake showed no such association, reinforcing that K2, not K1, is the relevant form for cardiovascular protection.

Why Knowledge Workers Are Particularly at Risk

If you’re working 8-12 hour days at a desk, there are several compounding factors that make K2 status worth paying attention to specifically.

The Vitamin D Problem

Vitamin D supplementation has become common, and for good reason — indoor sedentary workers are chronically deficient. But here’s what most people don’t realize: vitamin D significantly upregulates both osteocalcin and MGP production. More K2-dependent proteins being produced means a greater demand for K2. If you’re supplementing with vitamin D without adequate K2, you may be increasing production of proteins that then sit around in their inactive, non-functional forms.

Some researchers have suggested that high-dose vitamin D supplementation without adequate K2 may actually worsen soft tissue calcification risk, though this remains an area of ongoing investigation. What’s clear is that vitamin D and K2 work synergistically — both are needed for the calcium management system to function properly.

Diet Patterns

The typical knowledge worker diet — even a generally healthy one — tends to be low in fermented foods and organ meats, which are the primary dietary sources of K2. Cheese contains modest amounts of MK-8 and MK-9, and some K2 can be found in egg yolks and butter from grass-fed animals. But unless you’re eating natto regularly or consuming substantial amounts of these other foods, dietary K2 intake is likely well below what’s needed to fully activate K2-dependent proteins throughout the body.

Sedentary Behavior and Bone Density

Mechanical loading through weight-bearing activity is one of the primary stimuli for bone remodeling and osteocalcin production. Prolonged sedentary work reduces this mechanical stimulus. Combine reduced bone-building signaling with inadequate K2 to activate whatever osteocalcin is being produced, and you have a setup for gradual, asymptomatic bone density loss that won’t show up until it becomes a clinical problem in your 50s or 60s.

What the Research Actually Says About MK-7 Supplementation

The evidence base for MK-7 specifically has grown substantially over the past 15 years. Beyond the Rotterdam cohort data and the Knapen trial mentioned earlier, several important findings stand out.

A systematic review and meta-analysis found that vitamin K2 supplementation was associated with significantly reduced vertebral fracture risk and, in some populations, reduced hip and non-vertebral fracture risk as well (Cockayne et al., 2006). The effect sizes were meaningful, not marginal.

On the cardiovascular side, a three-year randomized controlled trial published in Thrombosis and Haemostasis demonstrated that daily MK-7 supplementation at 180 micrograms per day significantly reduced age-related arterial stiffness in healthy postmenopausal women, an effect that was most pronounced in women with the highest baseline levels of inactive MGP (Knapen et al., 2015). Arterial stiffness is one of the strongest independent predictors of cardiovascular events, so a nutrient intervention that measurably reduces it is clinically meaningful.

It’s also worth noting that K2 at typical supplemental doses has an excellent safety profile. Unlike vitamin A and vitamin D, K2 has not been associated with toxicity even at doses substantially above typical supplemental ranges. It does not interfere with anticoagulant medications at standard food-equivalent doses in the same way K1 does, though anyone on warfarin or similar drugs should consult their physician before supplementing.

Dosing, Timing, and Practical Considerations

The most commonly studied and recommended supplemental dose of MK-7 is 100–200 micrograms per day. The 180 mcg dose used in the Knapen cardiovascular study is often cited as the threshold for meaningful effects on MGP activation. Some practitioners recommend 100 mcg as a maintenance dose for generally healthy adults not on vitamin D supplementation, scaling up to 150–200 mcg for those taking moderate to high doses of vitamin D.

Because K2 is a fat-soluble vitamin, it’s absorbed most effectively when taken with a meal containing fat. Taking it alongside fish oil, with breakfast including eggs, or with a dinner containing olive oil all work well. The long half-life of MK-7 means daily supplementation is sufficient — you don’t need to worry about timing it precisely.

MK-7 derived from natto is the most bioavailable form. When choosing a supplement, look for MK-7 specifically (not just “vitamin K2” which may refer to MK-4), with transparent sourcing. The synthetic all-trans form should be specified — some cheaper products use a mixture of cis and trans isomers, with the cis form being biologically inactive.

The Broader Picture: Calcium Management as a System

Understanding vitamin K2 changes how you think about calcium and bone health fundamentally. It’s not simply a question of whether you’re getting enough calcium. It’s a question of whether you have the complete nutritional infrastructure to direct that calcium appropriately.

The system works roughly like this: vitamin D increases calcium absorption from the gut and stimulates production of calcium-binding proteins. Vitamin K2 activates those proteins through carboxylation. Magnesium supports vitamin D activation and bone matrix formation. Calcium is the raw material that the entire system manages. Pull out any one component and the system becomes less efficient — or, in the case of K2 deficiency with high calcium intake, potentially counterproductive.

For knowledge workers in their 20s through 40s, this is genuinely an area where small consistent investments pay off decades later. Arterial calcification and bone density loss are both slow, silent processes. The interventions that prevent them need to happen long before any symptoms appear.

The evidence for MK-7 isn’t at the level of a handful of large randomized trials, but it is mechanistically coherent, supported by epidemiological data with impressive effect sizes, and backed by multiple controlled intervention studies with meaningful outcomes. For a fat-soluble vitamin with an excellent safety profile that the vast majority of people are likely deficient in, the case for paying attention to your K2 status is about as strong as nutritional science gets outside of the most studied interventions.

Getting your K2 from natto is ideal if you can develop a taste for it. For everyone else, a high-quality MK-7 supplement taken with a fatty meal is a straightforward and well-supported approach to ensuring your calcium ends up exactly where it belongs.

Last updated: 2026-03-31

Sources

Cockayne, S., Adamson, J., Lanham-New, S., Shearer, M. J., Gilbody, S., & Torgerson, D. J. (2006). Vitamin K and the prevention of fractures: Systematic review and meta-analysis of randomized controlled trials. Archives of Internal Medicine, 166(12), 1256–1261.

Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H. J., van der Meer, I. M., Hofman, A., & Witteman, J. C. M. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam study. Journal of Nutrition, 134(11), 3100–3105.

Knapen, M. H. J., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507.

Knapen, M. H. J., Braam, L. A. J. L. M., Drummen, N. E., Bekers, O., Hoeks, A. P. G., & Vermeer, C. (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and Haemostasis, 113(5), 1135–1144.

Schurgers, L. J., Teunissen, K. J. F., Hamulyák, K., Knapen, M. H. J., Vik, H., & Vermeer, C. (2007). Vitamin K-containing dietary supplements: Comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood, 109(8), 3279–3283.

Does this match your experience?

My take: the research points in a clear direction here.

Have you ever wondered why this matters so much?

References

• Khandelwal, A. (2025). Vitamin D and Vitamin K: Synergistic Roles and Emerging Evidence for …. PMC. Link
• Author not specified (n.d.). Vitamin K2 as MK-7: The Unsung Nutrient Protecting Your Heart and …. Integrative Medicine: A Clinician’s Journal. Link
• Author not specified (n.d.). Vitamin K2 Benefits for the Heart: New Research on MK-7, Arterial …. drdidwal.com. Link
• Author not specified (n.d.). Vitamin K2 (MK-7). livhospital.com. Link
• Author not specified (n.d.). The Importance of Vitamin K2 in Bone Care. vegetology.com. Link
• Author not specified (n.d.). Did you know? More cardioprotective benefits for vitamin K2 were …. Nutraceutical Business Review. Link

Related Reading

• Static Stretching Before Exercise Is Wrong: 2026 Research Explains Why
• How to Teach Problem-Solving Skills [2026]
• How Astronauts Sleep in Space: The Science of Sleeping